{
  "paper_id": "PMC9916184",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916184/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Fig. 1.",
      "caption": "Kaplan–Meier analyses of first and fourth COVID-19 vaccine uptake in people with blood cancer and other disorders, immunocompromise, and the general population, in all age groups and those 60 years and over only.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "fig1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC9916184/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b015/9916184/cc3fe9508129/gr1_lrg.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Full population\nBlood cancer\nAplastic anaemia\nSickle cell disease\nSickle cell trait\n\n\n\nTotal (N)\n12,274,948\n97,707\n2583\n5087\n25,200\n\nVaccine Dose 1\n\nReceived at least 1 dose of vaccine\n9,794,885 (79.8)\n90,059 (92.2)\n2269 (87.8)\n3371 (66.3)\n16,474 (65.4)\n\n\n unvaccinated\n2,480,063 (20.2)\n7648 (7.8)\n314 (12.2)\n1716 (33.7)\n8726 (34.6)\n\n\n ChAdOx1\n4,488,704 (36.6)\n46,905 (48.0)\n1327 (51.4)\n1561 (30.7)\n7796 (30.9)\n\n\n BNT162b2\n4,935,864 (40.2)\n42,890 (43.9)\n917 (35.5)\n1757 (34.5)\n8174 (32.4)\n\n\n mRNA-1273\n368,647 (3.0)\n264 (0.3)\n19 (0.7)\n53 (1.0)\n504 (2.0)\n\nVaccine Dose 2\n\nReceived 2 doses of vaccine\n9,245,967 (75.3)\n87,603 (90.9)\n129 (4.99)\n3054 (60.0)\n15,021 (59.6)\n\n\n Unvaccinated\n3,027,609 (24.7)\n8732 (9.1)\n454 (17.6)\n2033 (40.0)\n10,179 (40.4)\n\n\n ChAdOx1\n4,370,200 (35.6)\n45,562 (47.3)\n1238 (47.9)\n1471 (28.9)\n7441 (29.5)\n\n\n BNT162b2\n4,538,372 (37.0)\n41,793 (43.4)\n874 (33.8)\n1544 (30.4)\n7169 (28.4)\n\n\n mRNA-1273\n336,282 (2.7)\n246 (0.3)\n12 (0.5)\n39 (0.8)\n411 (1.6)\n\nVaccine Dose 3\n\nReceived 3 doses of vaccine\n7,123,089 (58.0)\n78,289 (82.3)\n1745 (67.6)\n1919 (37.7)\n9083 (36.0)\n\n\n Unvaccinated\n5,149,310 (42.0)\n16,869 (17.7)\n838 (32.4)\n3168 (62.3)\n16,117 (64.0)\n\n\n ChAdOx1\n17,392 (0.1)\n412 (0.4)\n15 (0.6)\n8 (0.2)\n37 (0.1)\n\n\n BNT162b2\n5,545,366 (45.2)\n72,044 (75.7)\n1578 (61.1)\n1669 (32.8)\n7332 (29.1)\n\n\n mRNA-1273\n1,560,211 (12.7)\n5831 (6.1)\n147 (5.7)\n242 (4.8)\n1714 (6.8)\n\nVaccine Dose 4\n\nReceived 4 doses of vaccine\n418,246 (3.4)\n28,829 (31.3)\n635 (24.6)\n79 (1.6)\n191 (0.8)\n\n\n Unvaccinated\n11,851,120 (96.6)\n63,296 (68.7)\n1948 (75.4)\n5008 (98.4)\n25,009 (99.2)\n\n\n ChAdOx1\n473 (0.0)\n34 (0.0)\n0 (0.0)\n0 (0.0)\n\n\n\n BNT162b2\n265,651 (2.2)\n22,404 (24.3)\n507 (19.6)\n67 (1.3)\n146 (0.6)\n\n\n mRNA-1273\n152,111 (1.2)\n6391 (6.9)\n123 (4.8)\n12 (0.2)\n44 (0.2)\n\n\n\nOpen in a new tab\nData are N (% of column total) unless otherwise specified.Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Time to uptake of the first and fourth COVID-19 vaccines in all age groups and people aged 60 years and over are shown in Fig. 1.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 1,
    "claims_count": 10,
    "images_downloaded": 1,
    "tables_filtered": 5
  }
}